TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.

Peter Hillmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.